These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 26335372

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Copolymer micelles function as pH-responsive nanocarriers to enhance the cytotoxicity of a HER2 aptamer in HER2-positive breast cancer cells.
    Shen Y, Zhang J, Hao W, Wang T, Liu J, Xie Y, Xu S, Liu H.
    Int J Nanomedicine; 2018; 13():537-553. PubMed ID: 29416334
    [Abstract] [Full Text] [Related]

  • 3. An Intelligent DNA Nanorobot with in Vitro Enhanced Protein Lysosomal Degradation of HER2.
    Ma W, Zhan Y, Zhang Y, Shao X, Xie X, Mao C, Cui W, Li Q, Shi J, Li J, Fan C, Lin Y.
    Nano Lett; 2019 Jul 10; 19(7):4505-4517. PubMed ID: 31185573
    [Abstract] [Full Text] [Related]

  • 4. Improved in vitro efficacy of gold nanoconstructs by increased loading of G-quadruplex aptamer.
    Dam DH, Lee RC, Odom TW.
    Nano Lett; 2014 May 14; 14(5):2843-8. PubMed ID: 24689438
    [Abstract] [Full Text] [Related]

  • 5. Aptamer-Functionalized Gold Nanostars for on-Demand Delivery of Anticancer Therapeutics.
    Wu D, Zhao P, Wu L, Lin L, Yu G, Xu L, Yue J.
    ACS Appl Bio Mater; 2020 Jul 20; 3(7):4590-4599. PubMed ID: 35025458
    [Abstract] [Full Text] [Related]

  • 6. Grafting aptamers onto gold nanostars increases in vitro efficacy in a wide range of cancer cell types.
    Dam DH, Culver KS, Odom TW.
    Mol Pharm; 2014 Feb 03; 11(2):580-7. PubMed ID: 24422969
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cellular uptake, intracellular distribution and degradation of Her2-targeting silk nanospheres.
    Florczak A, Mackiewicz A, Dams-Kozlowska H.
    Int J Nanomedicine; 2019 Feb 03; 14():6855-6865. PubMed ID: 32021156
    [Abstract] [Full Text] [Related]

  • 10. Development of HER2-Specific Aptamer-Drug Conjugate for Breast Cancer Therapy.
    Jeong HY, Kim H, Lee M, Hong J, Lee JH, Kim J, Choi MJ, Park YS, Kim SC.
    Int J Mol Sci; 2020 Dec 21; 21(24):. PubMed ID: 33371333
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. NIR-cleavable drug adducts of gold nanostars for overcoming multidrug-resistant tumors.
    Del Valle AC, Su CK, Sun YC, Huang YF.
    Biomater Sci; 2020 Mar 31; 8(7):1934-1950. PubMed ID: 32039412
    [Abstract] [Full Text] [Related]

  • 13. Targeting HER2+ breast cancer cells: lysosomal accumulation of anti-HER2 antibodies is influenced by antibody binding site and conjugation to polymeric nanoparticles.
    Owen SC, Patel N, Logie J, Pan G, Persson H, Moffat J, Sidhu SS, Shoichet MS.
    J Control Release; 2013 Dec 10; 172(2):395-404. PubMed ID: 23880472
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biodistribution and in vivo toxicity of aptamer-loaded gold nanostars.
    Dam DH, Culver KS, Kandela I, Lee RC, Chandra K, Lee H, Mantis C, Ugolkov A, Mazar AP, Odom TW.
    Nanomedicine; 2015 Apr 10; 11(3):671-9. PubMed ID: 25461281
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nuclear targeting dynamics of gold nanoclusters for enhanced therapy of HER2+ breast cancer.
    Wang Y, Chen J, Irudayaraj J.
    ACS Nano; 2011 Dec 27; 5(12):9718-25. PubMed ID: 22053819
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cancer targeting with biomolecules: a comparative study of photodynamic therapy efficacy using antibody or lectin conjugated phthalocyanine-PEG gold nanoparticles.
    Obaid G, Chambrier I, Cook MJ, Russell DA.
    Photochem Photobiol Sci; 2015 Apr 27; 14(4):737-47. PubMed ID: 25604735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.